Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Claret, F, Vu, T, Shackleford, TJ, Allensworth, JL, Zhang, Q, Esteva, FJ, Drakos, E, Zhang, R, Tian, L, Rassidakis, GZ
Format:	Tagungsbericht
Sprache:	eng
Schlagworte:	Medicin och hälsovetenskap
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page	155
container_title
container_volume	50
creator	Claret, F Vu, T Shackleford, TJ Allensworth, JL Zhang, Q Esteva, FJ Drakos, E Zhang, R Tian, L Rassidakis, GZ
description
doi_str_mv	10.1016/S0959-8049(14)70603-3
format	Conference Proceeding
fullrecord	<record><control><sourceid>swepub</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_613619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_swepub_ki_se_613619</sourcerecordid><originalsourceid>FETCH-LOGICAL-s889-1545ce5d34515cac74a673be8fd4f132fe42988ff2f3ad3c81c047e2b83112083</originalsourceid><addsrcrecordid>eNp1jDFPwzAUhD2ARCn8BCSPMJj6xXZis6GoUFAlJOjGEDnOcwmUJLINVf89rSgwMd3p7rsj5Az4JXDIJ0_cKMM0l-Yc5EXBcy6YOCCj3_iIHMf4yjkvtOQj8nxva5iUsVNX1NIO13RY2Q0G2oT2s-2WNL0gDRjbmGznkKaezqaPGUs2LDFhs-uDHVqM1PeB1gFtTNTt2HBCDr1dRTzd65gsbqaLcsbmD7d35fWcRa0NAyWVQ9UIqUA56wpp80LUqH0jPYjMo8yM1t5nXthGOA2OywKzWguAjGsxJuz7Nq5x-KirIbTvNmyq3rbVPnrbOqxyEDmYLW_-5YfQN3-jnyEIrkDoAsQXjL9r_g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype></control><display><type>conference_proceeding</type><title>Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer</title><source>Access via ScienceDirect (Elsevier)</source><creator>Claret, F ; Vu, T ; Shackleford, TJ ; Allensworth, JL ; Zhang, Q ; Esteva, FJ ; Drakos, E ; Zhang, R ; Tian, L ; Rassidakis, GZ</creator><creatorcontrib>Claret, F ; Vu, T ; Shackleford, TJ ; Allensworth, JL ; Zhang, Q ; Esteva, FJ ; Drakos, E ; Zhang, R ; Tian, L ; Rassidakis, GZ</creatorcontrib><identifier>ISSN: 0959-8049</identifier><identifier>DOI: 10.1016/S0959-8049(14)70603-3</identifier><language>eng</language><subject>Medicin och hälsovetenskap</subject><ispartof>EUROPEAN JOURNAL OF CANCER, 2014, Vol.50, p.155</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,309,310,780,784,789,790,885,4050,4051,23930,23931,25140,27925</link.rule.ids><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:130513871$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Claret, F</creatorcontrib><creatorcontrib>Vu, T</creatorcontrib><creatorcontrib>Shackleford, TJ</creatorcontrib><creatorcontrib>Allensworth, JL</creatorcontrib><creatorcontrib>Zhang, Q</creatorcontrib><creatorcontrib>Esteva, FJ</creatorcontrib><creatorcontrib>Drakos, E</creatorcontrib><creatorcontrib>Zhang, R</creatorcontrib><creatorcontrib>Tian, L</creatorcontrib><creatorcontrib>Rassidakis, GZ</creatorcontrib><title>Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer</title><title>EUROPEAN JOURNAL OF CANCER</title><subject>Medicin och hälsovetenskap</subject><issn>0959-8049</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2014</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNp1jDFPwzAUhD2ARCn8BCSPMJj6xXZis6GoUFAlJOjGEDnOcwmUJLINVf89rSgwMd3p7rsj5Az4JXDIJ0_cKMM0l-Yc5EXBcy6YOCCj3_iIHMf4yjkvtOQj8nxva5iUsVNX1NIO13RY2Q0G2oT2s-2WNL0gDRjbmGznkKaezqaPGUs2LDFhs-uDHVqM1PeB1gFtTNTt2HBCDr1dRTzd65gsbqaLcsbmD7d35fWcRa0NAyWVQ9UIqUA56wpp80LUqH0jPYjMo8yM1t5nXthGOA2OywKzWguAjGsxJuz7Nq5x-KirIbTvNmyq3rbVPnrbOqxyEDmYLW_-5YfQN3-jnyEIrkDoAsQXjL9r_g</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Claret, F</creator><creator>Vu, T</creator><creator>Shackleford, TJ</creator><creator>Allensworth, JL</creator><creator>Zhang, Q</creator><creator>Esteva, FJ</creator><creator>Drakos, E</creator><creator>Zhang, R</creator><creator>Tian, L</creator><creator>Rassidakis, GZ</creator><scope>ADTPV</scope><scope>BNKNJ</scope></search><sort><creationdate>2014</creationdate><title>Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer</title><author>Claret, F ; Vu, T ; Shackleford, TJ ; Allensworth, JL ; Zhang, Q ; Esteva, FJ ; Drakos, E ; Zhang, R ; Tian, L ; Rassidakis, GZ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-s889-1545ce5d34515cac74a673be8fd4f132fe42988ff2f3ad3c81c047e2b83112083</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Medicin och hälsovetenskap</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Claret, F</creatorcontrib><creatorcontrib>Vu, T</creatorcontrib><creatorcontrib>Shackleford, TJ</creatorcontrib><creatorcontrib>Allensworth, JL</creatorcontrib><creatorcontrib>Zhang, Q</creatorcontrib><creatorcontrib>Esteva, FJ</creatorcontrib><creatorcontrib>Drakos, E</creatorcontrib><creatorcontrib>Zhang, R</creatorcontrib><creatorcontrib>Tian, L</creatorcontrib><creatorcontrib>Rassidakis, GZ</creatorcontrib><collection>SwePub</collection><collection>SwePub Conference</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Claret, F</au><au>Vu, T</au><au>Shackleford, TJ</au><au>Allensworth, JL</au><au>Zhang, Q</au><au>Esteva, FJ</au><au>Drakos, E</au><au>Zhang, R</au><au>Tian, L</au><au>Rassidakis, GZ</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer</atitle><btitle>EUROPEAN JOURNAL OF CANCER</btitle><date>2014</date><risdate>2014</risdate><volume>50</volume><spage>155</spage><pages>155-</pages><issn>0959-8049</issn><doi>10.1016/S0959-8049(14)70603-3</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0959-8049
ispartof	EUROPEAN JOURNAL OF CANCER, 2014, Vol.50, p.155
issn	0959-8049
language	eng
recordid	cdi_swepub_primary_oai_swepub_ki_se_613619
source	Access via ScienceDirect (Elsevier)
subjects	Medicin och hälsovetenskap
title	Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A26%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-swepub&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=Jab1/Csn5:%20a%20new%20player%20driving%20the%20resistance%20to%20HER2-targeted%20therapies%20for%20breast%20cancer&rft.btitle=EUROPEAN%20JOURNAL%20OF%20CANCER&rft.au=Claret,%20F&rft.date=2014&rft.volume=50&rft.spage=155&rft.pages=155-&rft.issn=0959-8049&rft_id=info:doi/10.1016/S0959-8049(14)70603-3&rft_dat=%3Cswepub%3Eoai_swepub_ki_se_613619%3C/swepub%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true